Oncolix's Reverse Merger Round

Oncolix raised a round of funding on August 07, 2017. Investors include Advanced Environmental Petroleum Producers.

Oncolix is a clinical-stage bio-pharmaceutical company developing Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The aim of Oncolix's product development is t…

Articles about Oncolix's Reverse Merger Round: